Type 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?
Diabetic Medicine · 2026-08 · 43 (8)
DOI: 10.1111/dme.70225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 08.02.2026. Verfasst von Lars Bakke Hindenes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Helse Sør-Øst RHF.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To describe updated trends in the incidence and prevalence of diagnosed type 2 diabetes in Norway by age, sex, country of birth and education.
Methods
A nationwide cohort study using registries on primary and specialist healthcare, dispensed drugs and demographic factors in Norway. We analysed incidence trends 2009–2021 using Poisson regression and JoinPoint.
Results
During 2009–2021, 195,935 incident type 2 diabetes cases were identified. After a decline in incidence 2009–2014, the incidence was largely stable over time, with a suggestive upward trend 2019–2021. The overall incidence rates were 651 per 100,000 person‐years in 2009 and 530 per 100,000 in 2021. There were 165,432 prevalent cases of type 2 diabetes in 2009 (5.5% of the population), consistently increasing throughout the study period to a peak at 259017 (7.6%) in 2021. The time trends were largely consistent across age, sex, country of birth and education. Inhabitants with lower education and born in Asia or Africa had substantially higher incidence and prevalence than those with higher education and born in Norway or other continents, respectively.
Conclusions
The previously described decline in incidence of diagnosed type 2 diabetes during 2009–2014 was not sustained, and prevalence continued to increase throughout 2009–2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Endocrinology, Preventive Medicine and Morbid Obesity, Oslo University Hospital, Oslo, Norway.
- Oslo Diabetes Research Centre, Oslo University Hospital, Oslo, Norway.
- Institute of Health, Oslo New University College, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Division of Public Health and Prevention, Norwegian Institute of Public Health, Oslo, Norway.
ORCID-Profile: Lars Bakke Hindenes, Paz Lopez-Doriga Ruiz, German Tapia, Inger Johanne Bakken, Elisabeth Qvigstad, Hanne L Gulseth, Lars C Stene
Förderung
- Helse Sør-Øst RHF
Zitieren
APA
Hindenes, L. B., Ruiz, P. L., Tapia, G., Bakken, I. J., Qvigstad, E., Gulseth, H. L., & Stene, L. C. (2026). Type 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?. Diabetic Medicine, 43(8). https://doi.org/10.1111/dme.70225
Vancouver
Hindenes LB, Ruiz PL, Tapia G, Bakken IJ, Qvigstad E, Gulseth HL, et al. Type 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?. Diabetic Medicine. 2026;43(8). doi:10.1111/dme.70225
BibTeX
@article{Hindenes2026,
author = {Hindenes, Lars Bakke and Ruiz, Paz Lopez-Doriga and Tapia, German and Bakken, Inger Johanne and Qvigstad, Elisabeth and Gulseth, Hanne L and Stene, Lars C},
title = {Type 2 diabetes in Norway 2009–2021: Have declining incidence rates continued?},
journal = {Diabetic Medicine},
year = {2026},
volume = {43},
number = {8},
doi = {10.1111/dme.70225}
}
EUVIMED